Navigation Links
CRF will Provide updates on several key cardiovascular trials at EuroPCR
Date:5/13/2014

NEW YORK, NY May 13, 2014 The Cardiovascular Research Foundation (CRF) will hold a special session providing updates on several key cardiovascular trials on Tuesday, May 20 at this year's EuroPCR meeting. The session will feature studies conducted by the CRF Clinical Trials Center, the academic research organization of CRF. EuroPCR will be held May 20-23, 2014 at the Palais Des Congrs de Paris in France.

Co-chaired by Gregg W. Stone, MD, Co-Director of the Medical Research & Education Division at CRF, and Ori Ben-Yehuda, MD, Executive Director of the CRF Clinical Trials Center, the session will present and discuss the latest investigations on vulnerable plaque, bioresorbable scaffolds, drug-eluting stents, antiplatelet medications, embolic protection stents, and mitral regurgitation.

"The session will focus on some of the most important trials currently in progress in the field of interventional cardiology," said Dr. Ben-Yehuda. "We are delighted to be presenting here at EuroPCR. Many of our studies are international and we work closely with our European colleagues in advancing the treatment of cardiovascular disease."

Planned and Ongoing Clinical Trials: A Status Update from the Cardiovascular Research Foundation
Tuesday, May 20, 3:20 4:20 PM
Room 253

PROSPECT II and PROSPECT ABSORB: Providing Regional Observations to Study Predictors of Events in the Coronary Tree
D. Erlinge

ABSORB IV: A Clinical Evaluation of Absorb Bioresorbable Vascular Scaffolds, the Everolimus-eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery lesions IV
G.W. Stone

HORIZONS-AMI II: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction II
G.W. Stone

MASTER II: MGuard Prime Stent System Clinical Trial in Patients with Acute STEMI II
G.W. Stone

COAPT: Cardiovascular Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients
G.W. Stone


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
3. Study of half siblings provides genetic clues to autism
4. Physicians mindfulness skills can improve care for patient and provider
5. Everyday fish oil capsule may provide kidney-related benefits
6. Partnership provides inclusive workout
7. 16th-century Korean mummy provides clue to hepatitis B virus genetic code
8. Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
9. InsuranceCalculator.net Now Provides Competitive Car Insurance Quotes To Missouri Drivers
10. SEOMiracle.com Provides SEO Services with PayPal Verified Option
11. InsuranceCalculator.net Now Provides Competitive Car Insurance Quotes To Maryland Drivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
Breaking Medicine Technology: